NIAID Banner Logo Image

Opportunistic Infections Citation List: July 19 - August 1, 2013

ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. Silver (I) Complexes as Precursors to Produce Silver Nanowires: Structure Characterization, Antimicrobial Activity and Cell Viability. El-Gamel, N.E. Dalton Transactions, 2013. 42(27): p. 9884-9892. PMID[23694860].

[PubMed]. OI_0719-080113.


2. Candida tropicalis Antifungal Cross-resistance Is Related to Different Azole Target (Erg11p) Modifications. Forastiero, A., A. Mesa-Arango, A. Alastruey-Izquierdo, L. Alcazar-Fuoli, L. Bernal-Martinez, T. Pelaez, J. Lopez, J. Grimalt, A. Gomez-Lopez, I. Cuesta, O. Zaragoza, and E. Mellado. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23877676].

[PubMed]. OI_0719-080113.


3. Activity of Antifungal Combinations against Aspergillus Species Evaluated by Isothermal Microcalorimetry. Furustrand Tafin, U., C. Orasch, and A. Trampuz. Diagnostic Microbiology and Infectious Disease, 2013. [Epub ahead of print]. PMID[23871413].

[PubMed]. OI_0719-080113.


4. Mechanism of Action of Novel Synthetic Dodecapeptides against Candida albicans. Maurya, I.K., C.K. Thota, J. Sharma, S.G. Tupe, P. Chaudhary, M.K. Singh, I.S. Thakur, M. Deshpande, R. Prasad, and V.S. Chauhan. Biochimica et Biophysica Acta, 2013. [Epub ahead of print]. PMID[23876294].

[PubMed]. OI_0719-080113.


5. Plants Traditionally Used Individually and in Combination to Treat Sexually Transmitted Infections in Northern Maputaland, South Africa: Antimicrobial Activity and Cytotoxicity. Naidoo, D., S.F. van Vuuren, R.L. van Zyl, and H. de Wet. Journal of Ethnopharmacology, 2013. [Epub ahead of print]. PMID[23880127].

[PubMed]. OI_0719-080113.


6. Use of Isothermal Microcalorimetry to Quantify the Influence of Glucose and Antifungals on the Growth of Candida albicans in Urine. Wernli, L., G. Bonkat, T.C. Gasser, A. Bachmann, and O. Braissant. Journal of Applied Microbiology, 2013. [Epub ahead of print]. PMID[23865534].

[PubMed]. OI_0719-080113.


7. A New Metabolic Pathway for Converting Blasticidin S in Aspergillus flavus and Inhibitory Activity of Aflatoxin Production by Blasticidin S Metabolites. Yoshinari, T., S. Sakuda, M. Watanabe, Y. Kamata, T. Ohnishi, and Y. Sugita-Konishi. Journal of Agricultural and Food Chemistry, 2013. [Epub ahead of print]. PMID[23879927].

[PubMed]. OI_0719-080113.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

8. Expression of the ARPC4 Subunit of Human Arp2/3 Severely Affects Mycobacterium tuberculosis Growth and Suppresses Immunogenic Response in Murine Macrophages. Ghosh, A., S. Tousif, D. Bhattacharya, S.K. Samuchiwal, K. Bhalla, M. Tharad, S. Kumar, P. Prakash, P. Kumar, G. Das, and A. Ranganathan. Plos One, 2013. 8(7): p. e69949. PMID[23894563].

[PubMed]. OI_0719-080113.


9. A Novel Combinatorial Biocatalytic Approach for Producing Antibacterial Compounds Effective against Mycobacterium tuberculosis (TB). McClay, K., B. Wan, Y. Wang, S. Cho, J. Yu, B. Santarsiero, S. Mehboob, M. Johnson, S. Franzblau, and R. Steffan. Applied Microbiology and Biotechnology, 2013. 97(16): p. 7151-7163. PMID[23749163].

[PubMed]. OI_0719-080113.


10. Cationic Antimicrobial Peptides and Biogenic Silver Nanoparticles Kill Mycobacteria without Eliciting DNA Damage and Cytotoxicity in Mouse Macrophages. Mohanty, S., P. Jena, R. Mehta, R. Pati, B. Banerjee, S. Patil, and A. Sonawane. Antimicrobial Agents and Chemotherapy, 2013. 57(8): p. 3688-3698. PMID[23689720].

[PubMed]. OI_0719-080113.


11. Ivermectin Lacks Antituberculous Activity. Muhammed Ameen, S. and M. Drancourt. Journal of Antimicrobial Chemotherapy, 2013. 68(8): p. 1936-1937. PMID[23587653].

[PubMed]. OI_0719-080113.


12. Discovery of an Acyclic Nucleoside Phosphonate That Inhibits Mycobacterium tuberculosis ThyX Based on the Binding Mode of a 5-Alkynyl Substrate Analogue. Parchina, A., M. Froeyen, L. Margamuljana, J. Rozenski, S. De Jonghe, Y. Briers, R. Lavigne, P. Herdewijn, and E. Lescrinier. ChemMedChem, 2013. 8(8): p. 1373-1383. PMID[23836539].

[PubMed]. OI_0719-080113.


13. Synthesis and Biological Evaluation of Cationic Fullerene Quinazolinone Conjugates and Their Binding Mode with Modeled Mycobacterium tuberculosis Hypoxanthine-guanine Phosphoribosyltransferase Enzyme. Patel, M.B., S.P. Kumar, N.N. Valand, Y.T. Jasrai, and S.K. Menon. Journal of Molecular Modeling, 2013. 19(8): p. 3201-3217. PMID[23625031].

[PubMed]. OI_0719-080113.


14. Discovery of New Inhibitors of Mycobacterium tuberculosis InhA Enzyme Using Virtual Screening and a 3D-pharmacophore-based Approach. Pauli, I., R.N. Santos, D.C. Rostirolla, L.K. Martinelli, R.G. Ducati, L.F. Timmers, L.A. Basso, D.S. Santos, R.V. Guido, A.D. Andricopulo, and O. Norberto de Souza. Journal of Chemical Information and Modeling, 2013. [Epub ahead of print]. PMID[23889525].

[PubMed]. OI_0719-080113.


15. Effect of Ribosome-targeting Antibiotics on Streptomycin-resistant Mycobacterium Mutants in the rpsL Gene. Pelchovich, G., A. Zhuravlev, and U. Gophna. International Journal of Antimicrobial Agents, 2013. 42(2): p. 129-132. PMID[23664678].

[PubMed]. OI_0719-080113.


16. Structure-guided Design of Novel Thiazolidine Inhibitors of O-Acetyl Serine Sulfhydrylase from Mycobacterium tuberculosis. Poyraz, O., V.U. Jeankumar, S. Saxena, R. Schnell, M. Haraldsson, P. Yogeeswari, D. Sriram, and G. Schneider. J Med Chem, 2013. [Epub ahead of print]. PMID[23879381].

[PubMed]. OI_0719-080113.


17. Two Human Host Defense Ribonucleases against Mycobacteria, the Eosinophil Cationic Protein (RNase 3) and RNase 7. Pulido, D., M. Torrent, D. Andreu, M.V. Nogues, and E. Boix. Antimicrobial Agents and Chemotherapy, 2013. 57(8): p. 3797-3805. PMID[23716047].

[PubMed]. OI_0719-080113.


18. Antituberculosis Thiophenes Define a Requirement for Pks13 in Mycolic Acid Biosynthesis. Wilson, R., P. Kumar, V. Parashar, C. Vilcheze, R. Veyron-Churlet, J.S. Freundlich, S.W. Barnes, J.R. Walker, M.J. Szymonifka, E. Marchiano, S. Shenai, R. Colangeli, W.R. Jacobs, Jr., M.B. Neiditch, L. Kremer, and D. Alland. Nature Chemical Biology, 2013. 9(8): p. 499-506. PMID[23770708].

[PubMed]. OI_0719-080113.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

19. Concise Synthesis and Antimalarial Activity of All Four Mefloquine Stereoisomers Using a Highly Enantioselective Catalytic Borylative Alkene Isomerization. Ding, J. and D.G. Hall. Angewandte Chemie International ed. in English, 2013. 52(31): p. 8069-8073. PMID[23818420].

[PubMed]. OI_0719-080113.


20. In Vitro and in Vivo Antimalarial Activity and Cytotoxicity of Extracts and Fractions from the Leaves, Root-bark and Stem-Bark of Triclisia gilletii. Kikueta, C.M., O.K. Kambu, A.P. Mbenza, S.T. Mavinga, B.M. Mbamu, P. Cos, L. Maes, S. Apers, L. Pieters, and R.K. Cimanga. Journal of Ethnopharmacology, 2013. [Epub ahead of print]. PMID[23876596].

[PubMed]. OI_0719-080113.


21. Brine Shrimp Toxicity and Antimalarial Activity of Some Plants Traditionally Used in Treatment of Malaria in Msambweni District of Kenya. Nguta, J.M. and J.M. Mbaria. Journal of Ethnopharmacology, 2013. 148(3): p. 988-992. PMID[23791809].

[PubMed]. OI_0719-080113.


22. Antimalarial, Hematological, and Antioxidant Effects of Methanolic Extract of Terminalia avicennioides in Plasmodium berghei-infected Mice. Omonkhua, A.A., M.C. Cyril-Olutayo, O.M. Akanbi, and O.A. Adebayo. Parasitology Research, 2013. [Epub ahead of print]. PMID[23873616].

[PubMed]. OI_0719-080113.


23. Evaluation of Novel Lipid Based Formulation of beta-Artemether and Lumefantrine in Murine Malaria Model. Patil, S., S. Suryavanshi, S. Pathak, S. Sharma, and V. Patravale. International Journal of Pharmaceutics, 2013. [Epub ahead of print]. PMID[23886650].

[PubMed]. OI_0719-080113.

ANTIPROTOZOAL COMPOUNDS

24. Enhancement of Protective Immune Response to Recombinant Toxoplasma gondii ROP18 Antigen by Ginsenoside Re. Qu, D., J. Han, and A. Du. Experimental Parasitology, 2013. [Epub ahead of print]. PMID[23896123].

[PubMed]. OI_0719-080113.


25. A Novel Calcium Dependent Protein Kinase Inhibitor as a Lead Compound for Treating Cryptosporidiosis. Castellanos-Gonzalez, A., A.C. White, Jr., K.K. Ojo, R.S. Vidadala, Z. Zhang, M.C. Reid, A.M. Fox, K.R. Keyloun, K. Rivas, A. Irani, S.M. Dann, E. Fan, J. Dustin, and W.C. Van Voorhis. Journal of Infectious Diseases, 2013. [Epub ahead of print]. PMID[23878324].

[PubMed]. OI_0719-080113.

Citations from the ISI Web of Knowledge Listings for O.I.

26. Antimicrobial and Antiviral Activity-guided Fractionation from Scutia buxifolia Reissek Extracts. Boligon, A.A., T.F. Kubica, D.N. Mario, T.F. de Brum, M. Piana, R. Weiblen, L. Lovato, S.H. Alves, R.C.V. Santos, C.F.D. Alves, and M.L. Athayde. Acta Physiologiae Plantarum, 2013. 35(7): p. 2229-2239. ISI[000320561500019].

[WOS]. OI_0719-080113.


27. Synthesis and Evaluation of a New Phosphorylated Ribavirin Prodrug. Dong, S.D., C.C. Lin, and M. Schroeder. Antiviral Research, 2013. 99(1): p. 18-26. ISI[000320906600004].

[WOS]. OI_0719-080113.


28. Antibacterial and Antifungal Activities of Selected Microalgae and Cyanobacteria.

Najdenski, H.M., L.G. Gigova, Iliev, II, P.S. Pilarski, J. Lukavsky, I.V. Tsvetkova, M.S. Ninova, and V.K. Kussovski. International Journal of Food Science and Technology, 2013. 48(7): p. 1533-1540. ISI[000320777600025].

[WOS]. OI_0719-080113.


29. Antioxidative, Antimicrobial and Cytotoxic Effects of the Phenolics of Leea indica Leaf Extract. Rahman, M.A., T. bin Imran, and S. Islam. Saudi Journal of Biological Sciences, 2013. 20(3): p. 213-225. ISI[000320658000001].

[WOS]. OI_0719-080113.


30. Syntheses and Evaluation of Macrocyclic Engelhardione Analogs as Antitubercular and Antibacterial Agents. Shen, L., M.M. Maddox, S. Adhikari, D.F. Bruhn, M. Kumar, R.E. Lee, J.G. Hurdle, R.E. Lee, and D.Q. Sun. Journal of Antibiotics, 2013. 66(6): p. 319-325. ISI[000321003000003].

[WOS]. OI_0719-080113.


31. Chemical Composition, Antimicrobial Properties and Toxicity Evaluation of the Essential Oil of Cupressus lusitanica Mill. Leaves from Cameroon. Teke, G.N., K.N. Elisee, and K.J. Roger. Bmc Complementary and Alternative Medicine, 2013. 13. ISI[000320646200001].

[WOS]. OI_0719-080113.


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2022